Target intelligence / Profile preview

Microtubule-associated protein 1 light chain 3 (MAP1LC3 (or LC3))

Target
MAP1LC3 (or LC3)
Molecular classification
Ubiquitin-like protein, Autophagy-related protein, ATG8 protein family, Other
01

Overview

Microtubule-associated protein 1 light chain 3 (MAP1LC3, commonly called LC3) is a ubiquitin-like protein essential for the autophagy pathway in eukaryotic cells[2][5]. LC3 functions in autophagosome biogenesis, selectively recognizing and capturing cargo for degradation, and is the most widely used molecular marker for monitoring autophagy. LC3 undergoes posttranslational modifications—such as cleavage and lipidation—that enable it to associate with autophagosomal membranes and serve as a molecular scaffold for autophagy receptors. It exists in several isoforms (LC3A, LC3B, LC3C, etc.), and MAP1LC3B (LC3B) is most studied for its role in both basal and stress-induced autophagy. Beyond cytoplasmic functions, LC3 is found in the nucleus, where it may contribute to nuclear component turnover, and its nucleocytoplasmic trafficking is regulated by stress and starvation conditions[1][2][5]. LC3 and its family members play central roles in cellular homeostasis, stress responses, and selective catabolic processes, making them important targets or biomarkers in cancer, neurodegeneration, and other disease contexts.

Other names
LC3LC3BMAP1LC3BMicrotubule-associated proteins 1A/1B light chain 3B
02

Mechanism of action

Inhibition of autophagic flux (via blockade of autophagosome-lysosome fusion); Modulation of LC3 lipidation and conversion between LC3-I and LC3-II

03

Biological functions

Autophagy (autophagosome biogenesis)Selective autophagy substrate recognitionMitophagy (selective mitochondrial autophagy)Membrane expansion and vesicle trafficking in autophagyProtein-protein interaction scaffold for cargo receptorsNuclear-cytosolic shuttling in response to stress/starvationRegulation of mitochondrial quantity/qualityPromotion of primary ciliogenesisEndoplasmic reticulum remodeling and turnover
04

Disease associations

CancerNeurodegenerative diseaseInflammationInfectionOther (autophagy-related disorders)
05

Safety considerations

Inhibition or excessive activation of autophagy may contribute to neurodegeneration, cancer, or inflammatory pathologyUse of autophagy inhibitors may cause increased susceptibility to some infections and might impair homeostatic cell clearance mechanisms
06

Interacting drugs

Chloroquine

2 more in the full profile.

07

Biomarkers

LC3B-II/LC3B-I ratio (biomarker for autophagic activity)Immunohistochemical staining for LC3 puncta in cells/tissue

Beyond the preview

Go deeper on Microtubule-associated protein 1 light chain 3 (MAP1LC3 (or LC3)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microtubule-associated protein 1 light chain 3 (MAP1LC3 (or LC3)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call